LP(A) LEVELS IN PATIENTS UNDERGOING AORTOCORONARY BYPASS-SURGERY

被引:18
作者
AVERNA, MR
BARBAGALLO, CM
OCELLO, S
DORIA, O
DAVI, G
SCAFIDI, V
ALBIERO, R
NOTARBARTOLO, A
机构
[1] UNIV PALERMO,IST MED INTERNA & GERIATR,CATTEDRA PATOL MED,I-90134 PALERMO,ITALY
[2] OSPED CIVICO,DIV CARDIOCHIRURG,PALERMO,ITALY
关键词
AORTOCORONARY BYPASS; LIPIDS; APOPROTEINS; LP(A);
D O I
10.1093/oxfordjournals.eurheartj.a060074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aims of this study were to evaluate plasma lipid, apoprotein and Lp(a) levels in patients with severe coronary atherosclerosis undergoing aorto-coronary bypass surgery (BP) and to relate these parameters to the involvement of one or more vessels. Seventy-seven male patients and 77 cardiovascular disease-free controls, matched for sex, age and body weight were studied. Higher triglyceride and apo B levels with lower HDL-cholesterol and apo A-I levels were found in BP patients in comparison with the controls. Lp(a) levels were slightly, but not significantly, increased. Moreover BP patients presented a significantly higher prevalence of HDL-cholesterol levels below 35 mg dl-1 (49·3% vs 22·1%) and Lp(a) levels above 70mg dl-1 (10·4% vs 1·3%) than the controls. When patients were divided according to the number of coronary vessels involved (one, two or three), no significant difference was found, with a trend to increase in Lp(a) mean levels and in prevalence of Lp (a) levels above 30 and 70 mg dl-1 in more severely diseased patients.These results suggest that patients with severe coronary artery disease undergoing aorto-coronary bvpass surgery show low HDL-cholesterol levels with high triglyceride levels. Moreover Lp(a) levels above 70 mg dl-1 are highly associated with severe coronary vessel stenosis. © 1992 The European Society of Cardiology.
引用
收藏
页码:1405 / 1409
页数:5
相关论文
共 38 条
[11]   THE TRIGLYCERIDE ISSUE - A VIEW FROM FRAMINGHAM [J].
CASTELLI, WP .
AMERICAN HEART JOURNAL, 1986, 112 (02) :432-437
[12]   QUANTITATION AND LOCALIZATION OF APOLIPOPROTEIN[A] AND APOLIPOPROTEIN-B IN CORONARY-ARTERY BYPASS VEIN GRAFTS RESECTED AT REOPERATION [J].
CUSHING, GL ;
GAUBATZ, JW ;
NAVA, ML ;
BURDICK, BJ ;
BOCAN, TMA ;
GUYTON, JR ;
WEILBAECHER, D ;
DEBAKEY, ME ;
LAWRIE, GM ;
MORRISETT, JD .
ARTERIOSCLEROSIS, 1989, 9 (05) :593-603
[13]   ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY [J].
DAHLEN, GH ;
GUYTON, JR ;
ATTAR, M ;
FARMER, JA ;
KAUTZ, JA ;
GOTTO, AM .
CIRCULATION, 1986, 74 (04) :758-765
[14]   DISCRIMINATIVE VALUE OF LIPIDS AND APOPROTEINS IN CORONARY HEART-DISEASE [J].
DEBACKER, G ;
ROSSENEU, M ;
DESLYPERE, JP .
ATHEROSCLEROSIS, 1982, 42 (2-3) :197-203
[15]   THE ASSOCIATION OF RISK-FACTORS WITH ARTERIOGRAPHICALLY DEFINED CORONARY-ARTERY DISEASE - WHAT IS THE APPROPRIATE CONTROL-GROUP [J].
FRIED, LP ;
PEARSON, TA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 125 (05) :844-853
[16]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[17]   PREVALENCE OF LIPOPROTEIN (A) [LP(A)] EXCESS IN CORONARY-ARTERY DISEASE [J].
GENEST, J ;
JENNER, JL ;
MCNAMARA, JR ;
ORDOVAS, JM ;
SILBERMAN, SR ;
WILSON, PWF ;
SCHAEFER, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (13) :1039-1045
[18]   LIPOPROTEIN LP(A) - A RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
HOEFLER, G ;
HARNONCOURT, F ;
PASCHKE, E ;
MIRTL, W ;
PFEIFFER, KH ;
KOSTNER, GM .
ARTERIOSCLEROSIS, 1988, 8 (04) :398-401
[19]   SERUM LP(A) LEVEL AS A PREDICTOR OF VEIN GRAFT STENOSIS AFTER CORONARY-ARTERY BYPASS-SURGERY IN PATIENTS [J].
HOFF, HF ;
BECK, GJ ;
SKIBINSKI, CI ;
JURGENS, G ;
ONEIL, J ;
KRAMER, J ;
LYTLE, B .
CIRCULATION, 1988, 77 (06) :1238-1244
[20]  
KANNEL WB, 1974, ANN INTERN MED, V19, P1